PIK3CA and breast cancer: Breast cancer cell lines with diminished PI3K activity via PIK3CA depletion or treatment with pan-PI3K inhibitor BKM120 exhibited an increase in ubiquitin E3 ligase Skp2, resulting in non-canonical AKT rebound activation [23].